4 free views remaining today

developmental and epileptic encephalopathy 8

ICD-10 Codes

Related ICD-10:

Description

Developmental and Epileptic Encephalopathies (DEEs) - A Heterogeneous Group of Disorders

Developmental and epileptic encephalopathies (DEEs) are a complex group of disorders characterized by early-onset, often severe epileptic seizures and EEG abnormalities [7][8]. These conditions typically begin in infancy or childhood and can be associated with developmental impairments, intellectual disability, and other neurological symptoms.

Key Features of DEEs

  • Early-onset, often severe epileptic seizures
  • EEG abnormalities
  • Developmental impairments, including intellectual disability
  • Heterogeneous group of disorders, meaning that each case may present differently

References:

[7] R Guerrini · 2023 · Cited by 75 - This source provides a comprehensive overview of DEEs, highlighting their complex nature and the need for further research.

[8] R Guerrini · 2023 · Cited by 75 - This reference emphasizes the importance of early diagnosis and intervention in managing DEEs.

Additional Characteristics

  • Early-onset, often severe epileptic seizures
  • EEG abnormalities
  • Heterogeneous group of disorders
  • Developmental impairments, including intellectual disability

Signs and Symptoms

Common Signs and Symptoms of Developmental and Epileptic Encephalopathy (DEE)

Developmental and epileptic encephalopathy (DEE) is a complex condition characterized by a combination of developmental delays, intellectual disability, and seizures. The following are some common signs and symptoms associated with DEE:

  • Seizures: Frequent seizures of multiple types, including atonic, tonic, or myoclonic seizures [6]
  • Developmental Delays: Delayed speech, language, and cognitive development [5]
  • Intellectual Disability: Mild to severe intellectual disability, which can impact daily life and social interactions [7]
  • Sleep Disturbances: Sleep disturbances, including insomnia or excessive daytime sleepiness [6]
  • Behavioral Difficulties: Behavioral difficulties, such as hyperactivity, aggression, or mood swings [6]
  • Cerebral Atrophy: Cerebral atrophy, which can lead to progressive neurological deficits [9]
  • Cerebral Hypomyelination: Cerebral hypomyelination, a condition characterized by abnormal brain development and structure [5]

It's essential to note that each individual with DEE may experience a unique combination of these signs and symptoms. A comprehensive evaluation by a healthcare professional is necessary for an accurate diagnosis and treatment plan.

References: [5] - Cerebral atrophy and hypomyelination are mentioned in the context as features of DEE. [6] - Seizures, sleep disturbances, and behavioral difficulties are listed as symptoms of DEE. [7] - Intellectual disability is mentioned as a common feature of SCN8A-related epilepsy with encephalopathy. [9] - Cerebral atrophy is mentioned as a progressive neurological deficit associated with DEE.

Additional Symptoms

  • Seizures
  • Developmental Delays
  • Intellectual Disability
  • Behavioral Difficulties
  • Sleep Disturbances
  • Cerebral Atrophy
  • Cerebral Hypomyelination

Diagnostic Tests

Diagnostic Tests for Developmental and Epileptic Encephalopathy 8 (DEE8)

Developmental and epileptic encephalopathy-8 (DEE8) is a rare genetic disorder characterized by seizure onset before 2 years of age and severe developmental delay. Diagnostic tests play a crucial role in identifying the underlying cause of DEE8.

  • Electroencephalogram (EEG): An EEG is often the first diagnostic test used to evaluate individuals with DEE8. It can help identify abnormal electrical activity in the brain, which may be indicative of epilepsy or other neurological conditions [3].
  • Magnetic Resonance Imaging (MRI): MRI scans can help rule out structural causes of seizures and developmental delays by visualizing the brain's anatomy [4].
  • Genetic Testing: Genetic testing is a valuable tool in diagnosing DEE8. It involves analyzing DNA samples to identify genetic mutations that may be causing the condition [5]. Targeted Next-Generation Sequencing (NGS) gene panel testing has been shown to be an efficient diagnostic tool in detecting the genetic basis of DEE in a large proportion of cases [7].
  • Other Diagnostic Tests: Other tests, such as metabolic testing and radiological imaging, may also be considered as part of the diagnostic workup for DEE8. However, these tests are typically used to rule out other conditions rather than directly diagnosing DEE8.

References

[1] Context result 2 [3] Context result 3 [4] Context result 4 [5] Context result 5 [7] Context result 7

Additional Diagnostic Tests

  • Magnetic Resonance Imaging (MRI)
  • Metabolic testing
  • Genetic Testing
  • Electroencephalogram (EEG)
  • Radiological imaging

Treatment

Treatment Options for Developmental and Epileptic Encephalopathy (DEE)

Developmental and epileptic encephalopathy (DEE) is a rare and severe form of epilepsy that requires specialized treatment. While there are no specific treatments that can cure DEE, various medications and therapies can help manage the condition.

  • Antiepileptic drugs: These are the primary treatment for DEE, but they often have limited effectiveness in controlling seizures. The goal of antiepileptic drug therapy is to reduce seizure frequency and severity.
  • Hormonal treatment: Hormonal imbalances can contribute to DEE, so hormonal treatments may be prescribed to address these issues.
  • Intravenous immunoglobulin (IVIG): IVIG has been shown to be effective in reducing seizures and improving developmental outcomes in some cases of DEE.

Challenges in Treating DEE

Treating DEE can be challenging due to the following reasons:

  • Limited response to antiepileptic drugs: Many patients with DEE do not respond well to conventional antiepileptic medications.
  • Developmental delay: The developmental delays associated with DEE can make it difficult to determine the most effective treatment approach.

Emerging Therapies

Researchers are exploring new therapies for DEE, including:

  • Gene therapy: Gene therapy aims to correct genetic mutations that contribute to DEE.
  • Stem cell therapy: Stem cell therapy involves using stem cells to repair damaged brain tissue and promote recovery.

It's essential to note that these emerging therapies are still in the experimental stages, and more research is needed to determine their effectiveness.

References

  • [8] Developmental and epileptic encephalopathies (DEEs) are a group of rare and severe epilepsies. DEEs commonly begin in infancy or childhood and are associated with frequent seizures of multiple different types.
  • [9] Developmental and epileptic encephalopathies (DEEs) are rare neurodevelopmental disorders characterised by early-onset and often intractable seizures and significant developmental delay.
  • [10] The concept of developmental and epileptic encephalopathy (DEE) refers to conditions where there is both developmental encephalopathy, which is directly due to the underlying etiology of the epilepsy, and epileptic encephalopathy, which implies that the epileptic activity itself causes cognitive and behavioral impairment.

Recommended Medications

  • Intravenous immunoglobulin (IVIG)
  • Antiepileptic drugs
  • Hormonal treatment

💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

Differential Diagnoses for Developmental and Epileptic Encephalopathy

Developmental and epileptic encephalopathy (DEE) is a severe form of epilepsy that affects cognitive and behavioral functions. When diagnosing DEE, it's essential to consider other conditions that may present with similar symptoms. Here are some differential diagnoses to consider:

  • Early Myoclonic Encephalopathy: This condition is characterized by early onset seizures, developmental delay, and encephalopathy. It often presents with myoclonic seizures, which can be a challenge to differentiate from DEE.
  • West Syndrome: Also known as infantile spasms, West syndrome is a severe form of epilepsy that affects infants. It's characterized by clusters of brief, shock-like muscle contractions and developmental delay.
  • Other Early-Onset Epileptic Encephalopathies: These conditions include early myoclonic encephalopathy, West syndrome, and other forms of epileptic encephalopathy that present with similar symptoms to DEE.

Key Considerations

When differentiating between these conditions, it's essential to consider the following factors:

  • Age of onset: Early-onset epilepsy is more likely to be associated with developmental delay and encephalopathy.
  • Type of seizures: Myoclonic seizures are often seen in early myoclonic encephalopathy, while

Additional Differential Diagnoses

Additional Information

oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#id
DOID:0080215
core#notation
DOID:0080215
oboInOwl#hasDbXref
MIM:300607
oboInOwl#hasExactSynonym
EIEE8
rdf-schema#label
developmental and epileptic encephalopathy 8
IAO_0000115
A developmental and epileptic encephalopathy characterized by seizures with onset before 2 years of age, severe developmental delay, and in some patients hyperekplexia that has_material_basis_in X-linked recessive inheritance of a mutation in the ARHGEF9 gene on chromosome Xq22.1.
rdf-schema#subClassOf
t353741
IDO_0000664
http://purl.obolibrary.org/obo/GENO_0000149
relatedICD
http://example.org/icd10/G93.45
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_2585
owl#annotatedSource
t353593

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.